(PharmaNewsWire.Com, January 05, 2018 ) Middle East And Africa Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of the menopause. It replaces hormones that are at a lower level as women approach the menopause. These days, hormone therapy is even employed in treatment of other health conditions like male hypogonadism, growth hormone deficiency, hypothyroidism etc. The Middle-East and Africa Hormone Replacement Therapy Market is estimated at USD 1.10 billion in 2016 and is predicted to reach USD 1.56 mbillion by 2021, growing at a CAGR of 7.24%.
The key growth driver for the hormone replacement therapy market in Middle-East region is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, presence of unmet medical needs which require the employment of hormone therapy etc. Coming to the African countries, the market here at present is mere low but given the demographic advantage, it can pick up within the next 10 years.
Along with lack of awareness about the HRT benefits, the other major factor acting as a hurdle for market growth is the cost of therapy, especially in the African countries. Usually, the hormone therapy costs around $ 10,000. This is a huge amount considering the economic conditions of people in most of the countries in the African region. Further, the risk of side effects, such as bloating, mood changes, and nausea, bleeding, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is restraining the growth of HRT market in both Middle-East and African countries. Along with this, women with high susceptibility to coronary diseases are kept away from taking hormone replacement therapy.
Market Segmentation By Hormone Type • Estrogen Replacement Therapy • Growth Hormone Replacement Therapy • Thyroid Replacement Therapy • Others By Route of Administration • Oral • Parenteral • Transdermal • Others
The Middle-East and Africa hormone replacement therapy is segmented on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. The estrogen replacement therapy is the major segment as its employed by majority women to treat menopause, and is followed by growth hormone replacement therapy. Further, on the basis of route of administration the market is classified as oral, transdermal, parenteral, and other routes. Moreover, on the basis of geography, the Middle-East & Africa hormone replacement therapy market is analysed under Middle East and Africa regions considering the major countries.
Some of the key players operating in the Middle-East and Africa hormone replacement industry are Novartis, Pfizer, Mylan Laboratories, Abbott Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer, and Novo Nordisk
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
